A randomized controlled trial of uplifting yang and dispersing stagnation, activating the channel and alleviating pain acupuncture therapy for migraine
- Conditions
- migraine
- Registration Number
- ITMCTR2000003241
- Lead Sponsor
- Chengdu University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Age is between 18-55 years old (the starting age is less than 50 years old), and the gender is not limited; the time of compulsory education >= 6 years;
2. Meet the ICHD-3 diagnostic criteria for migraine without aura;
3. In the past three months, the number of monthly attacks is greater than or equal to 2 times, and the number of headache days is less than 15 days per month;
4. Headache in patients at baseline is regarded as moderate headache (average VAS score 3-7);
5. have a history of migraine for more than one year;
6. Those who can complete the headache diary at the baseline period;
7. The patient himself signs the informed consent.
(Only patients who meet the above 7 items can be included in this study).
1. Patients with other primary headaches and headaches of unknown diagnosis;
2. Combined with serious primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic systems and other organic diseases;
3. People with a history of head trauma and mental and intellectual disabilities who cannot cooperate with the questionnaire;
4. Those with bleeding tendency, allergies and skin diseases;
5. Pregnant women and lactating women, those who have fertility requirements in the past six months;
6. Can't understand or record the headache diary;
7. Having the habit of taking analgesics and alcohol for a long time;
8. Received acupuncture treatment or other preventive treatment in the last 4 weeks;
9. Those who have participated in similar researches within 3 months.
(Anyone who meets any of the above should be excluded).
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of migraine attacks;
- Secondary Outcome Measures
Name Time Method Migraine Specific Quality of Life Question, MSQ;Headache duration (hours);Days of migraine attack;Percentage of patients taking acute analgesic;Treatment response rate;Headache impact scale (HIT-6);Calcitonin Gene related Peptide, CGRP;Patient treatment satisfaction evaluation;Intensity of migraine;TCM syndrome assessment scale;